Press Releases

CureDuchenne Media Statement Regarding Prosensa Announcement of Regulatory Path Forward for Drisapersen as a Potential Treatment for DMD

CureDuchenne, a nonprofit that raises awareness and funds research to find a cure for Duchenne muscular dystrophy, issued the following statement today regarding the announcement by Prosensa Holding N.V. (NASDAQ: RNA) that the United States Food and Drug Administration (FDA) has outlined a regulatory path forward, under an accelerated approval pathway, for drisapersen, a potential treatment for Duchenne Muscular Dystrophy (DMD).

CureDuchenne Founder Debra Miller is a Panelist at the California Women’s Conference

CureDuchenne Founder and CEO Debra Miller is a panelist at the California WomenÌ¢‰â‰ã¢s Conference on May 19 at the Long Beach Convention Center. Miller will participate in a panel called Ì¢‰âÒA New Approach to Non-Profit Impact.Ì¢‰âÂÌ_ She will speak about venture philanthropy and how CureDuchenne has created a successful business model to help accelerate Duchenne research.

Blingo to CureDuchenne Raised $175,000 for Muscular Dystrophy Research

CureDuchenne, a nonprofit that raises awareness and funds research to find a cure for Duchenne muscular dystrophy, held its inaugural Blingo to CureDuchenne event on May 3 at the Hyatt Regency in Philadelphia. Nearly 300 people, including PhiladelphiaÌ¢‰â‰ã¢s top business and community leaders, enjoyed an elegant evening of bingo and bling with celebrity guests while raising more than $175,000 to support the most promising research projects aimed at treating and curing Duchenne.

EY Announces CureDuchenne Founder and CEO Debra Miller is an Entrepreneur of the Year 2014 Award Finalist in Orange County

EY today announced that Debra Miller, founder and CEO of CureDuchenne, is a finalist for the EY Entrepreneur Of The YearÌ¢‰Û_å¢ 2014 Award in Orange County. The awards program recognizes entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance and personal commitment to their businesses and communities. Miller was selected as a finalist from nearly 80 applications by a panel of independent judges. Award winners will be announced at a special gala event on June 4, 2014 at The St. Regis Resort in Dana Point.

CureDuchenne Founder and CEO Debra Miller is an EY Entrepreneur of the Year 2014 Award Finalist in Orange County

CureDuchenne is pleased to announce that Debra Miller, founder and CEO of CureDuchenne, is a finalist for the EY Entrepreneur Of The YearÌ¢‰Û_å¢ 2014 Award in Orange County. The awards program recognizes entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance and personal commitment to their businesses and communities. Miller was selected as a finalist from nearly 80 applications by a panel of independent judges. Award winners will be announced at a special gala event on June 4, 2014 at The St. Regis Resort in Dana Point.

Champions to CureDuchenne Newport Beach Gala Raises More Than $360,000 to Fund Duchenne Muscular Dystrophy Research

CureDuchenne, a nonprofit that raises awareness and funds research to find a cure for Duchenne muscular dystrophy, held its annual Champions to CureDuchenne Newport Beach Gala on March 29 at the Balboa Bay Club & Resort. More than 250 guests attended the gala that celebrated CureDuchenneÌ¢‰â‰ã¢s 10 years of successfully advancing Duchenne research. The event raised more than $360,000 that will fund promising Duchenne research.

Chef Jamie Gwen to Be Guest at Champions to CureDuchenne Newport Beach Gala

Ì¢‰â‰ÛÏ CureDuchenne, a nonprofit that raises awareness and funds research to find a cure for Duchenne muscular dystrophy, announced today that Chef Jamie Gwen will create a special menu for the annual Champions to CureDuchenne Newport Beach Gala on Saturday, March 29 at the Balboa Bay Club & Resort. Proceeds of this event will fund promising research to find a cure for Duchenne, a progressive muscle-wasting disease that impacts 1 in 3,500 boys.